Juvenile dermatomyositis-associated calcinosis successfully treated with combined immunosuppressive, bisphosphonate, oral baricitinib and physical therapy

被引:7
|
作者
Agud-Dios, Manuel [1 ]
Arroyo-Andres, Jorge [1 ]
Rubio-Muniz, Carmen [1 ]
Zarco-Olivo, Carlos [1 ]
Calleja-Algarra, Alba [1 ]
de Inocencio, Jaime [2 ,3 ]
Palencia Perez, Sara Isabel [1 ]
机构
[1] Hosp Univ 12 Octubre, Dept Dermatol, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Pediat Rheumatol, Madrid, Spain
[3] Univ Complutense Madrid, Dept Publ Hlth & Maternal & Child Hlth, Madrid, Spain
关键词
D O I
10.1111/dth.15960
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:2
相关论文
共 30 条
  • [21] A Case of Rapidly Progressive Interstitial Pneumonia in Association with Amyopathic Dermatomyositis with Elevated Titers of Anti-MDA-5 Antibody, Successfully Treated with Rituximab in Addition to Standard Immunosuppressive Therapy
    Nishizawa, T.
    Kida, G.
    Tsukahara, Y.
    Emoto, K.
    Tsumiyama, E.
    Kriiwa, S.
    Oba, T.
    Kawabe, R.
    Sato, S.
    Akasaka, K.
    Ishii, H.
    Amano, M.
    Matsushima, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [22] Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tofacitinib
    Yamazoe, Masami
    Takeda, Kazuya
    Nagano, Yutaro
    Nagano, Kanami
    Kato, Koji
    Inoue, Takashi
    Horiuchi, Kazuhiro
    Kamada, Kazuro
    INTERNAL MEDICINE, 2024, 63 (18) : 2571 - 2578
  • [23] A case of atopic dermatitis-associated lichen amyloidosis successfully treated with oral cyclosporine and narrow band UVB therapy in succession
    Kang, Min Ju
    Kim, Hei Sung
    Kim, Hyung Ok
    Park, Young Min
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2009, 20 (06) : 368 - 370
  • [24] Rapidly Progressive Interstitial Lung Disease Associated with Dermatomyositis Treated with Combination of Immunosuppressive Therapy, Direct Hemoperfusion with a Polymyxin B Immobilized Fiber Column and Intravenous Immunoglobulin
    Takai, Motohisa
    Katsurada, Naoko
    Nakashita, Tamao
    Misawa, Masafumi
    Mochizuki, Takahiro
    Kaneko, Norihiro
    Motojima, Shinji
    Aoshima, Masahiro
    INTERNAL MEDICINE, 2015, 54 (17) : 2225 - 2229
  • [25] An Adolescent Case of Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis With Interstitial Lung Disease Successfully Treated by Multitarget Therapy Avoiding Cyclophosphamide: A Case Report and Literature Review
    Yokoyama, Tadafumi
    Inoue, Natsumi
    Sakumura, Naoto
    Tasaki, Yuko
    Wada, Taizo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [26] Anti-nuclear matrix protein 2 antibody-associated juvenile dermatomyositis with gastrointestinal perforations was successfully treated with traditional therapeutic drugs combined with vedolizumab: a case report after a long-term follow-up and a review of the literature
    Xu, Xue-mei
    Ye, Shuang
    Jin, Ying-ying
    Liu, Chen-xi
    Bao, Sheng-fang
    Huang, Hua
    Ding, Fei
    Yang, Zhen
    Jin, Yan-liang
    FRONTIERS IN PEDIATRICS, 2025, 12
  • [27] Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
    Matsuda, Kazuki M.
    Yoshizaki, Ayumi
    Kuzumi, Ai
    Fukasawa, Takemichi
    Ebata, Satoshi
    Yoshizaki-Ogawa, Asako
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2020, 47 (05): : 483 - 489
  • [28] Clinical Features and Treatment of Dermatomyositis Patients with Anti-CADM-140 (melanoma differentiation-associated protein 5: MDA5) Antibody; Recommendation of Combined Immunosuppressive Therapy with Intensive Intravenous Cyclophosphamide
    Nakashima, Ran
    Hosono, Yuji
    Yukawa, Naoichiro
    Yoshifuji, Hajime
    Kawabata, Daisuke
    Ohmura, Koichiro
    Usui, Takashi
    Fujii, Takao
    Mimori, Tsuneyo
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S83 - S83
  • [29] Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis
    Tsuji, Hideaki
    Nakashima, Ran
    Hosono, Yuji
    Imura, Yoshitaka
    Yagita, Masato
    Yoshifuji, Hajime
    Hirata, Shintaro
    Nojima, Takaki
    Sugiyama, Eiji
    Hatta, Kazuhiro
    Taguchi, Yoshio
    Katayama, Masaki
    Tanizawa, Kiminobu
    Handa, Tomohiro
    Uozumi, Ryuji
    Akizuki, Shuji
    Murakami, Kosaku
    Hashimoto, Motomu
    Tanaka, Masao
    Ohmura, Koichiro
    Mimori, Tsuneyo
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (03) : 488 - 498
  • [30] Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated With Combined Immunosuppressive Therapy
    Kang, Ben
    Choi, So Yoon
    Choi, Young Ok
    Kim, Min-Ji
    Kim, Kyunga
    Lee, Ji-Hyuk
    Choe, Yon Ho
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (06): : 644 - 652